Swethajit Biswas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Swethajit Biswas has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Craig H. Gerrand
Sarcoma Research Group, Northern Institute for Cancer Research (NICR), Newcastle University and North of England Bone and Soft Tissue Sarcoma Service, Framlington Place, Newcastle‐Upon‐Tyne, UK
1 shared publicationJohn Lunec
Sarcoma Research Group, Northern Institute for Cancer Research (NICR), Newcastle University and North of England Bone and Soft Tissue Sarcoma Service, Framlington Place, Newcastle‐Upon‐Tyne, UK
1 shared publication- Kenneth Samora Rankin
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
1 shared publication Mike Starkey
Oncology Research Group, Animal Health Trust (AHT), Lanwades Park, Kentford, Newmarket, Suffolk, UK
1 shared publicationSue Murphy
Oncology Research Group, Animal Health Trust (AHT), Lanwades Park, Kentford, Newmarket, Suffolk, UK
1 shared publication
Latest Publications
- 11 October 2011
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 58 (3) , 327-333
Of dogs and men: Comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma
The similarities between human and canine osteosarcoma with regard to histology, biological behavior and molecular genetic alterations suggest that the dog provides a supplementary model for the development and preclinical testing of novel therapeutics. Counter intuitively, careful examination of the differences between OS in the two species may also be rewarding in terms of increasing our understanding of the pathogenesis of this cancer. This review will discuss the arguments in favor of the “dog model” and outline how the evaluation of treatment strategies in dogs has indicated avenues for improvement of protocols for human patients. Pediatr Blood Cancer 2012; 58: 327–333.
- 11 October 2011
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 58 (3) , 327-333
Of dogs and men: Comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma
The similarities between human and canine osteosarcoma with regard to histology, biological behavior and molecular genetic alterations suggest that the dog provides a supplementary model for the development and preclinical testing of novel therapeutics. Counter intuitively, careful examination of the differences between OS in the two species may also be rewarding in terms of increasing our understanding of the pathogenesis of this cancer. This review will discuss the arguments in favor of the “dog model” and outline how the evaluation of treatment strategies in dogs has indicated avenues for improvement of protocols for human patients. Pediatr Blood Cancer 2012; 58: 327–333.